Massot-Tarrús, Andreu
White, Kevin
Mirsattari, Seyed M.
Funding for this research was provided by:
Eisai
UCB
Article History
First Online: 1 May 2019
Compliance with Ethical Standards
:
: A. Massot-Tarrús has received honoraria for speaking engagements and advisory boards from Bial, Eisai, and UCB Pharma, and research support from Eisai and UCB. S.M. Mirsattari is on the advisory boards and speaker bureaus for UCB Canada Inc., Eisai Limited, and Sunovion Pharmaceuticals Canada, Inc. Kevin White is an independent research consultant who was paid by Dr. Mirsattari to assist with the editing of this manuscript.
: Our original study presented as part of this review paper was approved by Western University’s Research Ethics Board, in London, Ontario, Canada.